Viewing Study NCT04265651


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-03-06 @ 12:27 AM
Study NCT ID: NCT04265651
Status: COMPLETED
Last Update Posted: 2025-10-22
First Post: 2020-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Infigratinib in Children With Achondroplasia
Sponsor: QED Therapeutics, a BridgeBio company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module